COVID-19 Severity Linked to Hyperglycemia
COVID-19 patients may be at a higher risk for complications and death if their blood glucose is elevated, even if they have not been diagnosed with diabetes, researchers say. Read more
COVID-19 patients may be at a higher risk for complications and death if their blood glucose is elevated, even if they have not been diagnosed with diabetes, researchers say. Read more
The U.S. Preventive Services Task Force (USPSTF) has issued a draft recommendation that pregnant patients who are asymptomatic be screened for gestational diabetes mellitus at or after 24 weeks of pregnancy, as research shows screening reduces risk for some pregnancy and newborn health problems. Read more
People who have type 2 diabetes are likely to have complicated medication regimens that involve taking multiple drugs (also known as polypharmacy). Complex medication regimens are associated with worse health outcomes, as it is more difficult to follow a complicated treatment correctly, and there is increased risk for drug interactions. Read more
It’s currently recommended that people with overweight or obesity be screened for type 2 diabetes beginning at age 40. A new draft set of guidelines from the U.S. Preventive Services Task Force recommends the age be lowered to 35, due to the high levels of overweight and obesity in Americans. Read more
Both genetic and environmental risk factors play a vital role in whether a person develops type 1 diabetes. A study looked at the impact of modifiable risk factors, such as obesity, in people who had high genetic risk for type 1. Read more
GIP and GLP-1 are substances produced in the body’s digestive tract, and they play important roles in regulating body weight and food intake. A recently published study on their effects suggests that they may one day be used to develop drugs to treat obesity and type 2 diabetes. Read more
Diabetes patients who used a medical device an software system called DIABEO to help manage their insulin dosage were more successfully able to reduce their HbA1c levels, a study found, since using the telemonitoring system allowed patients more support and guidance on controlling their glucose levels. Read more
The FDA has granted fast track designation to VX-880, which is a human stem cell-derived therapy for patients with type 1 diabetes. This islet cell therapy is designed to regulate glucose levels by restoring a patient’s pancreatic islet cell function, including insulin production. Read more
A clinical trial is being conducted in the United Kingdom to investigate whether the diabetes drug exenatide (Byetta) can be used to treat Parkinson’s Disease. Previous research has found that the risk for Parkinson’s is reduced in people who are treated with exenatide for their type 2 diabetes. Read more
Eating high amounts of red meat has already been linked with some forms of cancer. British researchers investigating whether meat consumption was linked to other diseases found that consumption of red meat, processed meat and poultry, either alone or together, at least three times a week was linked to a greater risk of nine different […]
Uncontrolled blood glucose in diabetes can lead to numerous debilitating complications, including high blood pressure, strokes, slow wound healing, and possibly amputations. Researchers have found that brain damage can also result from uncontrolled type 2 diabetes. Read more
A large study in the United Kingdom found that people with Down syndrome who contract COVID-19 are four times more likely to be hospitalized for the illness, and 10 times more likely to die, than the general population. Read more
Chronic kidney disease and cardiovascular disease are both common complications of type 2 diabetes. However, your risk of developing these complications can be impacted by various factors, including your ethnic background. Read more
Researchers are investigating a potential “inverse vaccine” for type 1 diabetes. This vaccine would use the body’s anti-inflammatory dendritic cells to retrain the immune system be less damaging to insulin-producing beta cells. If successful, this could be administered to patients in the early stages of type 1 to slow the disease’s progression. Read more
Metformin, a commonly-prescribed diabetes drug, may have other benefits, researchers say. A study found that metformin use in patients with type 2 diabetes is associated with a reduced risk of rehospitalization and death following surgery. Read more
Because diabetes damages blood vessels, people with diabetes have an increased risk for blood clots, heart attacks, stroke and vascular dementia. Researchers are examining the role of zinc, which helps the blood clot after injury, in these processes. Read more
Metformin is the typical first-line treatment for people with type 2 diabetes, but the ADA suggests early combination therapy with other medications should be used in patients with type 2 diabetes and chronic kidney disease or cardiovascular disease. Read more
A birthweight of 2.5 kg (about 5.5 pounds) or more is linked to increased risk of developing type 2 diabetes later in life, researchers say. A person’s susceptibility to type 2 diabetes is determined by various risk factors over the course of their lives. Read more
A recent study compared the effects of intermittent energy restriction (IER) or continuous energy restriction (CER) on participants with overweight or obesity, to see which has a more significant effect on weight loss. IER consisted of periods of a low energy diet of 500 to 600 kcal, alternating with periods of unrestricted food intake, versus […]
About 64% of adults hospitalized with COVID-19 had one or more of four underlying conditions, researchers say: obesity, diabetes, hypertension, and heart failure. This reinforces other studies which have found these conditions are strongly linked to poor COVID-19 outcomes. Read more